Comments
Loading...
Protara Therapeutics (TARA) Forecast
NewsEarningsProtara Therapeutics (TARA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestProtara Therapeutics (NASDAQ:TARA) Stock Quotes, Forecast and News Summary
Protara Therapeutics Stock (NASDAQ: TARA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Protara Therapeutics (TARA) stock?
You can purchase shares of Protara Therapeutics (NASDAQ:TARA) through any online brokerage.
Who are Protara Therapeutics (TARA) competitors?
Other companies in Protara Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), Precigen (NASDAQ:PGEN) and Inozyme Pharma (NASDAQ:INZY).
What is the forecast, or price target, for Protara Therapeutics (TARA) stock?
Protara Therapeutics has a consensus price target of $22.50.
What is the current price for Protara Therapeutics (TARA)?
The stock price for Protara Therapeutics (NASDAQ: TARA) is $5.23 last updated December 18, 2024 at 1:29 PM EST.
Does Protara Therapeutics (TARA) pay a dividend?
There are no upcoming dividends for Protara Therapeutics.
When is Protara Therapeutics (NASDAQ:TARA) reporting earnings?
Protara Therapeutics’s Q4 earnings are confirmed for Wednesday, March 12, 2025.
Is Protara Therapeutics (TARA) going to split?
There is no upcoming split for Protara Therapeutics.
What sector and industry does Protara Therapeutics (TARA) operate in?
Protara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.